North Growth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-195,000
| Closed | -$11.3M | – | 49 |
|
|
2023
Q3 | $11.3M | Sell |
195,000
-25,000
| -11% | -$1.45M | 2.5% | 13 |
|
|
2023
Q2 | $14.1M | Hold |
220,000
| – | – | 2.89% | 11 |
|
|
2023
Q1 | $15.2M | Sell |
220,000
-3,000
| -1% | -$208K | 3.25% | 8 |
|
|
2022
Q4 | $16.1M | Sell |
223,000
-32,000
| -13% | -$2.3M | 3.65% | 7 |
|
|
2022
Q3 | $18.1M | Hold |
255,000
| – | – | 4.52% | 3 |
|
|
2022
Q2 | $19.6M | Hold |
255,000
| – | – | 4.55% | 3 |
|
|
2022
Q1 | $18.6M | Buy |
255,000
+2,000
| +0.8% | +$146K | 3.43% | 8 |
|
|
2021
Q4 | $15.8M | Hold |
253,000
| – | – | 2.62% | 13 |
|
|
2021
Q3 | $15M | Hold |
253,000
| – | – | 2.64% | 12 |
|
|
2021
Q2 | $16.9M | Buy |
253,000
+20,000
| +9% | +$1.33M | 2.74% | 9 |
|
|
2021
Q1 | $14.7M | Buy |
233,000
+23,000
| +11% | +$1.45M | 2.6% | 11 |
|
|
2020
Q4 | $13M | Sell |
210,000
-16,000
| -7% | -$994K | 2.67% | 10 |
|
|
2020
Q3 | $13.6M | Buy |
226,000
+20,000
| +10% | +$1.21M | 3% | 10 |
|
|
2020
Q2 | $12.1M | Buy |
206,000
+20,000
| +11% | +$1.18M | 2.91% | 9 |
|
|
2020
Q1 | $10.4M | Buy |
186,000
+38,000
| +26% | +$2.12M | 2.92% | 11 |
|
|
2019
Q4 | $9.53M | Hold |
148,000
| – | – | 2.14% | 23 |
|
|
2019
Q3 | $7.53M | Buy |
148,000
+46,000
| +45% | +$2.34M | 1.82% | 29 |
|
|
2019
Q2 | $4.63M | Buy |
+102,000
| New | +$4.63M | 1.15% | 40 |
|